false
OasisLMS
Catalog
SCCM Resource Library
Can We Prevent Venous Thromboembolism in Sick Pati ...
Can We Prevent Venous Thromboembolism in Sick Patients?
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The presentation addressed preventing venous thromboembolism (VTE), particularly in pediatric patients, amid its rising prevalence. Current guidelines from the American Society of Hematology primarily rely on adult data due to limited pediatric-specific research. Key points include the difference in VTE presentation between adults and children, particularly noting catheter-associated DVTs as a significant issue in children. Early intervention within three days of catheter insertion is critical, with low molecular weight heparin preferred over unfractionated heparin for prophylaxis. Despite some promising results, bleeding risks remain a concern. Ongoing studies, like the CRETE studies, aim to improve understanding and prevention strategies, focusing on age-specific prophylaxis efficacy and separating the risk of clotting from bleeding. The presentation underscores the need for high-quality, pediatric-specific data to refine VTE prevention and treatment, focusing heavily on personalized risk assessments and innovative anticoagulation approaches.
Asset Caption
One-Hour Concurrent Session | Pediatric Venous Thromboembolism: An Update on Predictive Risk Factors, Prevention, and Treatment
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
venous thromboembolism
pediatric patients
catheter-associated DVTs
low molecular weight heparin
CRETE studies
×
Please select your language
1
English